Intrauterine contraception as an alternative to interval tubal sterilization

Contraception

Volumn 77, Issue 1, 2008, Pages 6-9

  Grimes, David A ^a   Mishell Jr , Daniel R ^b  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER INTRAUTERINE DEVICE; IBUPROFEN; LEVONORGESTREL; PLACEBO;

ARTICLE; CANCER RISK; CLINICAL TRIAL; FEMALE STERILIZATION; HUMAN; INTERMETHOD COMPARISON; INTRAUTERINE CONTRACEPTIVE DEVICE; LIFE EXPECTANCY; MORBIDITY; MORTALITY; PAIN; PREGNANCY; UTERINE TUBE STERILIZATION; WOMEN'S HEALTH;

CONTRACEPTION; FEMALE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; STERILIZATION, TUBAL; UNITED STATES;

EID: 38149008841     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2007.09.012     Document Type: Article

References (35)

1. Inki P. Long-term use of the levonorgestrel-releasing intrauterine system. Contraception 75 (2007) S161-S166
2. Mansour D. Copper IUD and LNG IUS compared with tubal occlusion. Contraception 75 (2007) S144-S151
3. Chandra A., Martinez G.M., Mosher W.D., Abma J.C., and Jones J. Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth. Vital Health Stat, Series 23 25 (2005) 1-160
4. Hubacher D., Reyes V., Lillo S., Zepeda A., Chen P.L., and Croxatto H. Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. Am J Obstet Gynecol 195 (2006) 1272-1277
5. Van Ee R., Hemrika D.J., De Blok S., Van Der Linden C., and Lip H. Effects of ketoprofen and mesosalpinx infiltration on postoperative pain after laparoscopic sterilization. Obstet Gynecol 88 (1996) 568-572
6. Benhamou D., Narchi P., Mazoit J.X., and Fernandez H. Postoperative pain after local anesthetics for laparoscopic sterilization. Obstet Gynecol 84 (1994) 877-880
7. Peterson H.B., Xia Z., Hughes J.M., Wilcox L.S., Tylor L.R., and Trussell J. The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization. Am J Obstet Gynecol 174 (1996) 1161-1168 [discussion 1168-70]
8. World Health Organization. Long-term reversible contraception. Twelve years of experience with the TCu380A and TCu220C. Contraception 56 (1997) 341-352
9. Sivin I. Utility and drawbacks of continuous use of a copper T IUD for 20 years. Contraception 75 (2007) S70-S75
10. Andersson K., Odlind V., and Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. Contraception 49 (1994) 56-72
11. Sivin I., el Mahgoub S., McCarthy T., et al. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study. Contraception 42 (1990) 361-378
12. Jamieson D.J., Kaufman S.C., Costello C., Hillis S.D., Marchbanks P.A., and Peterson H.B. A comparison of women's regret after vasectomy versus tubal sterilization. Obstet Gynecol 99 (2002) 1073-1079
13. Schmidt J.E., Hillis S.D., Marchbanks P.A., Jeng G., and Peterson H.B. Requesting information about and obtaining reversal after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization. Fertil Steril 74 (2000) 892-898
14. Skjeldestad F.E. Conception rates post IUD removal. In: Bardin C.W., and Mishell Jr. D.R. (Eds). Proceedings from the Fourth International Conference on IUDs (1994), Butterworth-Heinemann, Boston 63-75
15. Wilson J.C. A prospective New Zealand study of fertility after removal of copper intrauterine contraceptive devices for conception and because of complications: a four-year study. Am J Obstet Gynecol 160 (1989) 391-396
16. Belhadj H., Sivin I., Diaz S., et al. Recovery of fertility after use of the levonorgestrel 20 mcg/d or Copper T 380 Ag intrauterine device. Contraception 34 (1986) 261-267
17. Andersson K., Batar I., and Rybo G. Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T. Contraception 46 (1992) 575-584
18. Van Voorhis B.J. Comparison of tubal ligation reversal procedures. Clin Obstet Gynecol 43 (2000) 641-649
19. Trussell J., Guilbert E., and Hedley A. Sterilization failure, sterilization reversal, and pregnancy after sterilization reversal in Quebec. Obstet Gynecol 101 (2003) 677-684
20. Witsenburg C., Dieben S., Van der Westerlaken L., Verburg H., and Naaktgeboren N. Cumulative live birth rates in cohorts of patients treated with in vitro fertilization or intracytoplasmic sperm injection. Fertil Steril 84 (2005) 99-107
21. Grimes D.A. Intrauterine device and upper-genital-tract infection. Lancet 356 (2000) 1013-1019
22. Jamieson D.J., Hillis S.D., Duerr A., Marchbanks P.A., Costello C., and Peterson H.B. Complications of interval laparoscopic tubal sterilization: findings from the United States Collaborative Review of sterilization. Obstet Gynecol 96 (2000) 997-1002
23. Escobedo L.G., Peterson H.B., Grubb G.S., and Franks A.L. Case-fatality rates for tubal sterilization in U.S. hospitals, 1979 to 1980. Am J Obstet Gynecol 160 (1989) 147-150
24. Franks A.L., Beral V., Cates Jr. W., and Hogue C.J. Contraception and ectopic pregnancy risk. Am J Obstet Gynecol 163 (1990) 1120-1123
25. Curtis K.M., Marchbanks P.A., and Peterson H.B. Neoplasia with use of intrauterine devices. Contraception 75 (2007) S60-S69
26. Hankinson S.E., Hunter D.J., Colditz G.A., et al. Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study. JAMA 270 (1993) 2813-2818
27. Kjaer S.K., Mellemkjaer L., Brinton L.A., Johansen C., Gridley G., and Olsen J.H. Tubal sterilization and risk of ovarian, endometrial and cervical cancer. A Danish population-based follow-up study of more than 65,000 sterilized women. Int J Epidemiol 33 (2004) 596-602
28. Green A., Purdie D., Bain C., et al. Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer. Survey of Women's Health Study Group. Int J Cancer 71 (1997) 948-951
29. Narod S.A., Sun P., Ghadirian P., et al. Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. Lancet 357 (2001) 1467-1470
30. Chiou C.F., Trussell J., Reyes E., et al. Economic analysis of contraceptives for women. Contraception 68 (2003) 3-10
31. Steiner M.J., Trussell J., Mehta N., Condon S., Subramaniam S., and Bourne D. Communicating contraceptive effectiveness: a randomized controlled trial to inform a World Health Organization family planning handbook. Am J Obstet Gynecol 195 (2006) 85-91
32. Varma R., Sinha D., and Gupta J.K. Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS) - a systematic enquiry and overview. Eur J Obstet Gynecol Reprod Biol 125 (2006) 9-28
33. Curtis K.M., Mohllajee A.P., and Peterson H.B. Regret following female sterilization at a young age: a systematic review. Contraception 73 (2006) 205-210
34. Skjeldestad F., and Bratt H. Fertility after complicated and non-complicated use of IUDs. A controlled prospective study. Adv Contracept 4 (1988) 179-184
35. Walsh T., Grimes D., Frezieres R., Nelson A., Bernstein L., Coulson A., et al. Randomised controlled trial of prophylactic antibiotics before insertion of intrauterine devices. IUD Study Group. Lancet 351 (1998) 1005-1008